Remimazolam: The future of its sedative potential

Remimazolam (CNS 7056) is a new drug innovation in anesthesia. It combines the properties of two unique drugs already established in anesthesia - Midazolam and remifentanil. It acts on GABA receptors like midazolam and has organ-independent metabolism like remifentanil. It is likely to be the sedati...

Full description

Bibliographic Details
Main Authors: Basavana Gouda Goudra, Preet Mohinder Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Saudi Journal of Anaesthesia
Subjects:
Online Access:http://www.saudija.org/article.asp?issn=1658-354X;year=2014;volume=8;issue=3;spage=388;epage=391;aulast=Goudra